1. Home
  2. JNJ
  3. JNJ News

Latest Johnson & Johnson (JNJ) News on January 22, 2025

J&J, Procter & Gamble, United Airlines: Earnings movers
JNJ

Yahoo Finance Video

an hour ago

J&J, Procter & Gamble, United Airlines: Earnings movers

JNJ

MT Newswires

an hour ago

Sector Update: Health Care Stocks Flat to Lower Premarket Wednesday

Johnson & Johnson Beats Earnings Estimates and Forecasts 2025 Growth
JNJ

Barrons.com

an hour ago

Johnson & Johnson Beats Earnings Estimates and Forecasts 2025 Growth

Johnson & Johnson Issues Guidance for Higher 2025 Results Following Fourth-Quarter Beat
JNJ

MT Newswires

2 hours ago

Johnson & Johnson Issues Guidance for Higher 2025 Results Following Fourth-Quarter Beat

JNJ

MT Newswires

2 hours ago

Sector Update: Health Care

J&J Tops Q4 Adjusted Earnings Estimates, But 2025 Sales Outlook Falls Short
JNJ

Investopedia

2 hours ago

J&J Tops Q4 Adjusted Earnings Estimates, But 2025 Sales Outlook Falls Short

Johnson & Johnson Q4 Earnings: Cancer Drugs Performance Drives Revenue Beat, Issues Strong FY25 Outlook
JNJ

Benzinga

2 hours ago

Johnson & Johnson Q4 Earnings: Cancer Drugs Performance Drives Revenue Beat, Issues Strong FY25 Outlook

Johnson & Johnson Earnings Narrowly Top But Dow Giant's Sales Guidance Light
JNJ

Investor's Business Daily

3 hours ago

Johnson & Johnson Earnings Narrowly Top But Dow Giant's Sales Guidance Light

JNJ

MT Newswires

a day ago

Johnson & Johnson Says Spravato Approved by US FDA as Monotherapy for Major Depressive Disorder

SPRAVATO® (esketamine) approved in the U.S. as the first and only monotherapy for adults with treatment-resistant depression
JNJ

PR Newswire

a day ago

SPRAVATO® (esketamine) approved in the U.S. as the first and only monotherapy for adults with treatment-resistant depression

JNJ

MT Newswires

a day ago

Barclays Adjusts Price Target on Johnson & Johnson to $159 From $160, Maintains Equalweight Rating

The Art of Valuation: Discovering Johnson & Johnson's Intrinsic Value
JNJ

GuruFocus.com

a day ago

The Art of Valuation: Discovering Johnson & Johnson's Intrinsic Value

Here's Why Johnson & Johnson (NYSE:JNJ) Can Manage Its Debt Responsibly
JNJ

Simply Wall St.

a day ago

Here's Why Johnson & Johnson (NYSE:JNJ) Can Manage Its Debt Responsibly

Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.
JNJ

Motley Fool

a day ago

Want Decades of Passive Income? 2 Stocks to Buy Now and Hold Forever.

Can the 8 Worst-Performing Dow Jones Stocks in 2024 Beat the S&P 500 in 2025?
JNJ

Motley Fool

a day ago

Can the 8 Worst-Performing Dow Jones Stocks in 2024 Beat the S&P 500 in 2025?

3 Unstoppable Dividend-Growth Stocks Yielding More Than 3% That Income-Seeking Investors Want to Buy in 2025 and Hold Forever
JNJ

Motley Fool

a day ago

3 Unstoppable Dividend-Growth Stocks Yielding More Than 3% That Income-Seeking Investors Want to Buy in 2025 and Hold Forever

Trump's inauguration looms as earnings season rolls on: What to know this week
JNJ

Yahoo Finance

3 days ago

Trump's inauguration looms as earnings season rolls on: What to know this week

Is Johnson & Johnson (JNJ) the Best Cheap Stock to Buy for 2025?
JNJ

Insider Monkey

4 days ago

Is Johnson & Johnson (JNJ) the Best Cheap Stock to Buy for 2025?

Count on Dividend King Pepsi (PEP) for Stability in a Volatile Market
JNJ

TipRanks

4 days ago

Count on Dividend King Pepsi (PEP) for Stability in a Volatile Market

Tariff threats, drug pricing will be 2 key pharma issues during Trump's first year
JNJ

Yahoo Finance

4 days ago

Tariff threats, drug pricing will be 2 key pharma issues during Trump's first year

Why Is Cliff Asness Bullish On Johnson & Johnson (JNJ)?
JNJ

Insider Monkey

4 days ago

Why Is Cliff Asness Bullish On Johnson & Johnson (JNJ)?

3 Super-Safe Dividend Stocks to Buy for 2025 and Beyond
JNJ

Motley Fool

4 days ago

3 Super-Safe Dividend Stocks to Buy for 2025 and Beyond

JNJ

MT Newswires

5 days ago

Johnson & Johnson Q4 EPS, Revenue Estimates Nudged Higher, BofA Says

Netflix's Strategic Shift Faces Test As Streaming Giant, Dow Stocks Head Into Earnings
JNJ

Investor's Business Daily

5 days ago

Netflix's Strategic Shift Faces Test As Streaming Giant, Dow Stocks Head Into Earnings

Mega M&A at JP Morgan Conference 2025 — is biopharma M&A poised for a rebound?
JNJ

Pharmaceutical Technology

5 days ago

Mega M&A at JP Morgan Conference 2025 — is biopharma M&A poised for a rebound?

Should Weakness in Johnson & Johnson's (NYSE:JNJ) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?
JNJ

Simply Wall St.

5 days ago

Should Weakness in Johnson & Johnson's (NYSE:JNJ) Stock Be Seen As A Sign That Market Will Correct The Share Price Given Decent Financials?

Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know
JNJ

Zacks

6 days ago

Johnson & Johnson (JNJ) Gains As Market Dips: What You Should Know

Insights Into Johnson & Johnson (JNJ) Q4: Wall Street Projections for Key Metrics
JNJ

Zacks

6 days ago

Insights Into Johnson & Johnson (JNJ) Q4: Wall Street Projections for Key Metrics

RYBREVANT® plus chemotherapy approved in Canada as first and only targeted treatment to reduce risk of disease progression or death by more than half in second-line EGFR-mutated advanced lung cancer
JNJ

CNW Group

6 days ago

RYBREVANT® plus chemotherapy approved in Canada as first and only targeted treatment to reduce risk of disease progression or death by more than half in second-line EGFR-mutated advanced lung cancer

J&J Seeks FDA Nod for Non-Muscle Invasive Bladder Cancer Drug
JNJ

Zacks

6 days ago

J&J Seeks FDA Nod for Non-Muscle Invasive Bladder Cancer Drug

By the numbers: J&J, GSK lead J.P. Morgan deal announcements in 2025, the largest turnout in years
JNJ

Pharma Voice

6 days ago

By the numbers: J&J, GSK lead J.P. Morgan deal announcements in 2025, the largest turnout in years

J&J's AAA Rating in Jeopardy as Acquisition Sparks Debt Concerns
JNJ

GuruFocus.com

7 days ago

J&J's AAA Rating in Jeopardy as Acquisition Sparks Debt Concerns

J&J’s Top Rating at Risk Because of Intra-Cellular Deal
JNJ

Bloomberg

7 days ago

J&J’s Top Rating at Risk Because of Intra-Cellular Deal

JNJ

Morningstar Research

7 days ago

Analyst Report: Johnson & Johnson

JNJ

MT Newswires

7 days ago

Johnson & Johnson Submits New Drug Application for TAR-200 Drug-Releasing System for Bladder Cancer

New Drug Application initiated with U.S. FDA for TAR-200, the first and only intravesical drug releasing system for patients with BCG-unresponsive high-risk non-muscle-invasive bladder cancer
JNJ

PR Newswire

7 days ago

New Drug Application initiated with U.S. FDA for TAR-200, the first and only intravesical drug releasing system for patients with BCG-unresponsive high-risk non-muscle-invasive bladder cancer

Aggressive protection of Stelara may indicate J&J’s immunology strategy
JNJ

Pharmaceutical Technology

7 days ago

Aggressive protection of Stelara may indicate J&J’s immunology strategy

Got $200? 2 Dividend Stocks to Buy and Hold Forever
JNJ

Motley Fool

7 days ago

Got $200? 2 Dividend Stocks to Buy and Hold Forever

Johnson & Johnson (JNJ) Among the Best Dividend Kings to Buy Now
JNJ

Insider Monkey

8 days ago

Johnson & Johnson (JNJ) Among the Best Dividend Kings to Buy Now

J&J to leverage Intra-Cellular Therapies’ neurology portfolio
JNJ

Pharmaceutical Technology

8 days ago

J&J to leverage Intra-Cellular Therapies’ neurology portfolio

What Lies Ahead for Dow ETF in Q4 Earnings?
JNJ

Zacks

8 days ago

What Lies Ahead for Dow ETF in Q4 Earnings?

Why Intra-Cellular (ITCI) Led the Monday Upsurge?
JNJ

Insider Monkey

8 days ago

Why Intra-Cellular (ITCI) Led the Monday Upsurge?

Oric Pharmaceuticals announces clinical supply agreement with Janssen
JNJ

TipRanks

8 days ago

Oric Pharmaceuticals announces clinical supply agreement with Janssen

Unlocking Intrinsic Value: Analysis of Johnson & Johnson
JNJ

GuruFocus.com

8 days ago

Unlocking Intrinsic Value: Analysis of Johnson & Johnson

ITCI Stock Surges 34% as J&J Reveals $14.6 Billion Acquisition Plan
JNJ

GuruFocus.com

8 days ago

ITCI Stock Surges 34% as J&J Reveals $14.6 Billion Acquisition Plan

The Hottest Ticket Across Corporate America: Trump’s Inauguration
JNJ

The Wall Street Journal

8 days ago

The Hottest Ticket Across Corporate America: Trump’s Inauguration

JNJ

Morningstar Research

8 days ago

Analyst Report: Johnson & Johnson

JPMorgan Healthcare Conference: AI, billion-dollar deals
JNJ

Yahoo Finance Video

9 days ago

JPMorgan Healthcare Conference: AI, billion-dollar deals

J&J Announces A Splashy $14.6 Billion Deal, While Lilly Tacks On A Cancer Drug
JNJ

Investor's Business Daily

9 days ago

J&J Announces A Splashy $14.6 Billion Deal, While Lilly Tacks On A Cancer Drug

Johnson & Johnson Strikes $14.6 Billion Deal to Acquire Intra-Cellular Therapies
JNJ

MT Newswires

9 days ago

Johnson & Johnson Strikes $14.6 Billion Deal to Acquire Intra-Cellular Therapies

Johnson & Johnson Buys Intra-Cellular Therapeutics In A Whopping $14.6 Billion Deal
JNJ

Investor's Business Daily

9 days ago

Johnson & Johnson Buys Intra-Cellular Therapeutics In A Whopping $14.6 Billion Deal

Intra-Cellular Therapies Stock Pops as Johnson & Johnson Buys Firm for $14.6B
JNJ

Investopedia

9 days ago

Intra-Cellular Therapies Stock Pops as Johnson & Johnson Buys Firm for $14.6B

JNJ

MT Newswires

9 days ago

Johnson & Johnson to Acquire Intra-Cellular Therapies for $14.6 Billion

Update: Johnson & Johnson acquires Intra-Cellular Therapies
JNJ

Pharmaceutical Technology

9 days ago

Update: Johnson & Johnson acquires Intra-Cellular Therapies

Johnson & Johnson in $14.6 Billion Deal to Buy Biotech Intra-Cellular
JNJ

Barrons.com

9 days ago

Johnson & Johnson in $14.6 Billion Deal to Buy Biotech Intra-Cellular

JNJ

MT Newswires

9 days ago

Market Chatter: Johnson & Johnson to Acquire Intra-Cellular Therapies for $14.6 Billion

Johnson & Johnson to Acquire Intra-Cellular in $14.6 Billion Deal
JNJ

The Wall Street Journal

9 days ago

Johnson & Johnson to Acquire Intra-Cellular in $14.6 Billion Deal

Cramer on Johnson & Johnson (JNJ): A Value Trap Amid Lawsuits and Setbacks
JNJ

Insider Monkey

12 days ago

Cramer on Johnson & Johnson (JNJ): A Value Trap Amid Lawsuits and Setbacks

4 Top Dividend Growth Stocks to Build Your Portfolio Around in 2025
JNJ

Motley Fool

12 days ago

4 Top Dividend Growth Stocks to Build Your Portfolio Around in 2025

FDA Accepts J&J's Filing for Autoimmune Disease Drug Nipocalimab
JNJ

Zacks

12 days ago

FDA Accepts J&J's Filing for Autoimmune Disease Drug Nipocalimab

JNJ

MT Newswires

12 days ago

Goldman Sachs Adjusts Price Target on Johnson & Johnson to $158 From $159, Keeps Neutral Rating

2 Dow Stocks to Buy Hand Over Fist in 2025 and 1 to Avoid
JNJ

Motley Fool

12 days ago

2 Dow Stocks to Buy Hand Over Fist in 2025 and 1 to Avoid

Contineum concludes enrolment in Phase II multiple sclerosis therapy trial
JNJ

Clinical Trials Arena

13 days ago

Contineum concludes enrolment in Phase II multiple sclerosis therapy trial

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises
JNJ

Zacks

13 days ago

How to Find Strong Medical Stocks Slated for Positive Earnings Surprises

JNJ

MT Newswires

13 days ago

Johnson & Johnson Says Nipocalimab Granted FDA Priority Review in Myasthenia Gravis

J&J Pauses Sales of Atrial Fibrillation Device, Stock Down
JNJ

Zacks

13 days ago

J&J Pauses Sales of Atrial Fibrillation Device, Stock Down

Nipocalimab granted U.S. FDA Priority Review for the treatment of generalized myasthenia gravis
JNJ

PR Newswire

13 days ago

Nipocalimab granted U.S. FDA Priority Review for the treatment of generalized myasthenia gravis

JNJ

MT Newswires

14 days ago

Johnson & Johnson Says Investigational Alzheimer's Therapy Receives US FDA 'Fast Track' Designation

Johnson & Johnson's Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer's Disease
JNJ

PR Newswire

14 days ago

Johnson & Johnson's Posdinemab and Tau Active Immunotherapy Receive U.S. FDA Fast Track Designations for the Treatment of Alzheimer's Disease

Johnson & Johnson (JNJ): A Bull Case Theory
JNJ

Insider Monkey

14 days ago

Johnson & Johnson (JNJ): A Bull Case Theory

JNJ

Argus Research

14 days ago

Technical Assessment: Bullish in the Intermediate-Term

J&J reports positive topline outcomes from Phase III NSCLC combo therapy trial
JNJ

Clinical Trials Arena

14 days ago

J&J reports positive topline outcomes from Phase III NSCLC combo therapy trial

Johnson & Johnson (JNJ) Advances While Market Declines: Some Information for Investors
JNJ

Zacks

15 days ago

Johnson & Johnson (JNJ) Advances While Market Declines: Some Information for Investors

Top Research Reports for NVIDIA, Meta Platforms & Johnson & Johnson
JNJ

Zacks

15 days ago

Top Research Reports for NVIDIA, Meta Platforms & Johnson & Johnson

J&J Says Lung Cancer Combo Improves Survival More Than Standard of Care
JNJ

Bloomberg

15 days ago

J&J Says Lung Cancer Combo Improves Survival More Than Standard of Care

JNJ

MT Newswires

15 days ago

Johnson & Johnson Reports 'Statistically Significant' Data From Trial of Rybrevant, Lazcluze Combination to Treat Lung Cancer

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) show statistically significant and clinically meaningful improvement in overall survival versus osimertinib
JNJ

PR Newswire

15 days ago

RYBREVANT® (amivantamab-vmjw) plus LAZCLUZE™ (lazertinib) show statistically significant and clinically meaningful improvement in overall survival versus osimertinib

Invest with Confidence: Intrinsic Value Unveiled of Johnson & Johnson
JNJ

GuruFocus.com

15 days ago

Invest with Confidence: Intrinsic Value Unveiled of Johnson & Johnson

Subcutaneous options offer convenience for patients — and a valuable window for drugmakers
JNJ

Pharma Voice

15 days ago

Subcutaneous options offer convenience for patients — and a valuable window for drugmakers

Is it a Good Idea to Invest in Vanda Pharmaceuticals Stock Now?
JNJ

Zacks

16 days ago

Is it a Good Idea to Invest in Vanda Pharmaceuticals Stock Now?

JNJ

Argus Research

16 days ago

Weekly Stock List

How Are Companies Using AI Agents? Here’s a Look at Five Early Users of the Bots
JNJ

The Wall Street Journal

16 days ago

How Are Companies Using AI Agents? Here’s a Look at Five Early Users of the Bots

4 closely-watched FDA approval dates in 2025 from Vertex, Novo, J&J and more
JNJ

Pharma Voice

16 days ago

4 closely-watched FDA approval dates in 2025 from Vertex, Novo, J&J and more

This Johnson & Johnson Insider Reduced Their Stake By 37%
JNJ

Simply Wall St.

18 days ago

This Johnson & Johnson Insider Reduced Their Stake By 37%

5 Low-Leverage Stocks Worth Adding to Your Portfolio in 2025
JNJ

Zacks

20 days ago

5 Low-Leverage Stocks Worth Adding to Your Portfolio in 2025

Johnson & Johnson Declares Dividend, Short Interest Declines
JNJ

GuruFocus.com

20 days ago

Johnson & Johnson Declares Dividend, Short Interest Declines

Neumora Therapeutics Stock Crashes 83% After Depression Drug Flops
JNJ

Investor's Business Daily

20 days ago

Neumora Therapeutics Stock Crashes 83% After Depression Drug Flops

Johnson & Johnson Announces Quarterly Dividend for First Quarter 2025
JNJ

Business Wire

20 days ago

Johnson & Johnson Announces Quarterly Dividend for First Quarter 2025

Navigating Market Uncertainty: Intrinsic Value of Johnson & Johnson
JNJ

GuruFocus.com

20 days ago

Navigating Market Uncertainty: Intrinsic Value of Johnson & Johnson

The Descent of an Army Vet Turned Corporate Consultant Named in the New Year’s Attack
JNJ

The Wall Street Journal

20 days ago

The Descent of an Army Vet Turned Corporate Consultant Named in the New Year’s Attack

Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?
JNJ

Zacks

21 days ago

Will Johnson & Johnson (JNJ) Beat Estimates Again in Its Next Earnings Report?

The 5 worst-performing stocks on the Dow Jones Industrial Average in 2024
JNJ

TheStreet

21 days ago

The 5 worst-performing stocks on the Dow Jones Industrial Average in 2024

Johnson & Johnson (JNJ) Ascends While Market Falls: Some Facts to Note
JNJ

Zacks

22 days ago

Johnson & Johnson (JNJ) Ascends While Market Falls: Some Facts to Note

Is Johnson & Johnson (JNJ) Among the Best Low Volatility Stocks to Buy Right Now?
JNJ

Insider Monkey

22 days ago

Is Johnson & Johnson (JNJ) Among the Best Low Volatility Stocks to Buy Right Now?

Investors in Johnson & Johnson (NYSE:JNJ) have unfortunately lost 8.8% over the last three years
JNJ

Simply Wall St.

22 days ago

Investors in Johnson & Johnson (NYSE:JNJ) have unfortunately lost 8.8% over the last three years

Here’s Why WisdomTree U.S. LargeCap Dividend Fund (DLN) Is One of the Best Performing Dividend ETFs in 2024
JNJ

Insider Monkey

22 days ago

Here’s Why WisdomTree U.S. LargeCap Dividend Fund (DLN) Is One of the Best Performing Dividend ETFs in 2024

Is Johnson & Johnson (JNJ) the Best Pharma Dividend Stock to Buy In 2024?
JNJ

Insider Monkey

23 days ago

Is Johnson & Johnson (JNJ) the Best Pharma Dividend Stock to Buy In 2024?

5 Unbeatable Stocks I'm Eager to Buy in 2025
JNJ

Motley Fool

23 days ago

5 Unbeatable Stocks I'm Eager to Buy in 2025

Leerink sees positive readthrough for Kymera Therapeutics from J&J-Kaken deal
JNJ

TipRanks

a month ago

Leerink sees positive readthrough for Kymera Therapeutics from J&J-Kaken deal

JNJ Inks Licensing Deal With Kaken for Eczema Candidate KP-723
JNJ

Zacks

a month ago

JNJ Inks Licensing Deal With Kaken for Eczema Candidate KP-723

Share on Social Networks: